Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
US Army
Novartis
McKesson
McKinsey
Julphar
Mallinckrodt
AstraZeneca
Farmers Insurance
Colorcon

Generated: October 17, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,591,454

« Back to Dashboard

Summary for Patent: 5,591,454

Title: Method for lowering blood glucose
Abstract:The invention disclosed comprises a method for administering the antidiabetic drug glipizide to a patient in need of glipizide in need of antidiabetic therapy.
Inventor(s): Kuczynski; Anthony L. (Mountain View, CA), Ayer; Atul D. (Palo Alto, CA), Wong; Patrick S.-L. (Palo Alto, CA)
Assignee: ALZA Corporation (Palo Alto, CA)
Application Number:08/442,040
Patent Claim Types:
see list of patent claims
Use; Dosage form; Composition;

No matches for this query

International Patent Family for Patent: 5,591,454

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Denmark0490991► Subscribe
European Patent Office0490991► Subscribe
Spain2060199► Subscribe
Finland104950► Subscribe
Greece900100659► Subscribe
Greece1000932► Subscribe
Hong Kong116897► Subscribe
Ireland903166► Subscribe
Ireland62594► Subscribe
JapanH05500222► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Daiichi Sankyo
Fuji
Chinese Patent Office
Express Scripts
Citi
Cantor Fitzgerald
Novartis
QuintilesIMS
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot